Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BB Farma is a prominent Italian pharmaceutical company specializing in the parallel import and export of branded medicinal products within the European Economic Area. Established in 1995, the company focuses on optimizing the pharmaceutical supply chain by sourcing high-quality medicines from lower-cost EU markets and distributing them to healthcare providers and wholesalers. BB Farma operates a state-of-the-art facility authorized for secondary packaging and repackaging, ensuring strict compliance with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) standards. Their extensive portfolio covers a broad spectrum of therapeutic areas, including oncology, cardiology, and neurology. By leveraging price differentials across Europe, BB Farma provides cost-effective medication options to the Italian and European healthcare systems. The company is an active member of the European Association of Euro-Pharmaceutical Companies (EAEPC).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BB Farma.